Shares of iSpecimen gained after securing suppliers for the flu-like human metapneumovirus, a virus which causes upper respiratory infections. The stock rose 22%, to $3.50, in after-hours trading Thursday. Shares ended the regular session 8% higher, at $2.85, putting them down 71% over the last year.